Lamy, Martine http://orcid.org/0000-0001-5873-0813
Pedapati, Ernest V.
Dominick, Kelli L.
Wink, Logan K.
Erickson, Craig A.
Article History
First Online: 20 July 2020
Compliance with ethical standards
:
: The authors declare that no sources of funding were used to assist with the preparation of this review.
: The authors declare that they have no interests that compete directly with this work, though Dr. Lamy, Dr. Dominick, Dr. Wink, Dr. Pedapati, and Dr. Erickson do receive research support from various sources for other work. Dr. Lamy’s current research is supported by OVID Therapeutics and the Simon’s Foundation. Dr. Dominick’s current research is supported by OVID therapeutics and Roche Pharmaceuticals. Dr. Wink’s current and/or past research is supported by the Simons Research Foundation, Autism Speaks, Riovant Sciences Ltd, and Cures Within Reach. She is an inventor on intellectual property held by Cincinnati Children’s Hospital Research Foundation for a treatment in autism spectrum disorder. Dr. Wink has also served as a past consultant for Otsuka and Ovid. Dr. Pedapati receives research support from Cincinnati Children’s Hospital Research Foundation and the National Institutes of Health. Dr. Erickson has received current and/or past research support from the National Institutes of Health, the United States Department of Defense, the United States Centers for Disease Control, the John Merck Fund, Autism Speaks, the Simons Foundation, Cincinnati Children's Hospital Research Foundation, the FRAXA Research Foundation, the National Fragile X Foundation, the Roche Group, Seaside Therapeutics, Novartis, Neuren, Alcobra, and Indiana University School of Medicine. He is a past consultant to Alcobra, the Roche Group, and Novartis. He is a current consultant to Fulcrum Therapeutics. He holds equity interest in and is a consultant for Confluence Pharmaceuticals. He is the inventor on intellectual property held by Cincinnati Children's Hospital Research Foundation and Indiana University describing methods for diagnosis and treatment methods in autism spectrum disorder and fragile X syndrome.